Nikolai Slavov

Professor,  Bioengineering
Founding Director,  Parallel Squared Technology Institute
Allen Distinguished Investigator,  Allen Frontiers Group
Director,  Single-Cell Proteomics Center
Affiliated Faculty,  Biology
Affiliated Faculty,  Chemistry and Chemical Biology

Research Focus

Single-cell proteomics, immunology, cancer drug resistance, translational regulation, quantitative systems biology, mass spectrometry, RNA decoding, protein synthesis and degradation, macrophage polarization, aging, neurodegenerative diseases

About

Nikolai Slavov received undergraduate education from MIT and a doctoral degree from Princeton University for characterizing the coordination of cellular growth with gene expression and metabolism.

The Slavov laboratory pioneered experimental and computational methods for single-cell proteomics and used them to connect protein covariation across single cells to functional phenotypes, including macrophage polarization, emergence of drug resistance priming, early mammalian development, and stem cell differentiation. These technologies provided a foundation for establishing Parallel Squared Technology Institute (PTI).

Prof. Slavov organizes the annual single-cell proteomics conference and contributes to organizing other leading conferences, including NeurIPS.

Education

  • PhD (2010), Botstein Laboratory, Princeton University
  • BS (2004), Biology, Massachusetts Institute of Technology

Honors & Awards

  • HUPO Discovery in Proteomic Sciences Award
  • 2022 College of Engineering Faculty Fellow
  • Allen Distinguished Investigator Award
  • Excellence in Mentoring Award
  • NIH Director’s New Innovator Award
  • SPARC Award from the Broad Institute of MIT and Harvard
  • Princeton University Dean’s Award
  • IRCSET Postgraduate Research Fellowship
  • Finalist in the Young European Entrepreneur Competition
  • Princeton Graduate Fellowship
  • MIT Undergraduate Fellowship
  • Eureka Fellowship for Academic Excellence
  • Bronze Medal in the 31st International Chemistry Olympiad
  • National Diploma for Exceptional Achievements in Chemistry

Leadership Positions

 

Professional Affiliations

Research Overview

Single-cell proteomics, immunology, cancer drug resistance, translational regulation, quantitative systems biology, mass spectrometry, RNA decoding, protein synthesis and degradation, macrophage polarization, aging, neurodegenerative diseases

Single-cell proteomics by mass-spectrometry

Many biological processes stem from the coordinated interactions of molecularly and functionally diverse cells. However, this diversity is relatively unexplored at the proteome level because of the limitations of conventional affinity-based reagents for quantifying proteins in single cells. To alleviate these limitations, in 2017 our laboratory introduced Single Cell ProtEomics by Mass Spectrometry (SCoPE-MS). Since then, we developed more powerful and fully automated methods, including SCoPE2pSCoPE, and plexDIA.

Single-cell proteomics by Mass-spec (SCoPE-MS)

Taking advantage of strategies for advancing data acquisition and mass spectra identification, we developed methods that increase the sensitivity, data completeness and flexibility of single-cell protein analysis. These methods allow prioritization of thousands of proteins or parallelization in the mass domain by plexDIA, which supports parallel analysis of both single-cells and peptides. The multiplexing in the mass domain can be complemented by time domain multiplexing using timePlex, which enabled combinatorial increase in throughput as demonstrated by research at PTI. To facilitate accessibility, we introduced robust protocols and recommended best practices.

Single-cell proteomics by Mass-spec

Dynamics of protein synthesis and degradation

Cellular protein concentrations are maintained through a balance of synthesis and clearance. Clearance occurs through both protein degradation and growth-dependent dilution. We have found that the impact of clearance in context-dependent and large, sometimes account for over 50 % of the measured variance in protein abundance. We study this contribution of protein degradation to shaping protein variation both across the proteome and across cell states.

Alternate RNA decoding

Amino acid substitutions may substantially alter protein stability and function, but the contribution of substitutions arising from alternate translation (deviations from the genetic code) is unknown. We have identified 60,024 high confidence substitutions corresponding to 8,801 unique sites in proteins from 1,990 genes. Some substitutions are shared across samples, while others exhibit strong tissue-type and cancer specificity. Surprisingly, products of alternate translation are more abundant than their canonical counterparts for hundreds of proteins, suggesting sense codon recoding. Recoded proteins include transcription factors, proteases, signaling proteins, and proteins associated with neurodegeneration. Mechanisms contributing to substitution abundance include protein stability, codon frequency, codon-anticodon mismatches, and RNA modifications. Some substitutions are shared across samples, while others exhibit strong tissue-type and cancer specificity. Surprisingly, products of alternate translation are more abundant than their canonical counterparts for hundreds of proteins, suggesting sense codon recoding. Recoded proteins include transcription factors, proteases, signaling proteins, and proteins associated with neurodegeneration. Mechanisms contributing to substitution abun-dance include protein stability, codon frequency, codon-anticodon mismatches, and RNA modifications. We characterize sequence motifs around alternatively translated amino acids and how substitution ratios vary across protein domains, tissue types and cancers. Both the sequence and the tissue-specificity of alternatively translated proteins are conserved between human and mouse. These results demonstrate the contribution of alternate translation to diversifying mammalian proteomes, and its association with protein stability, tissue-specific proteomes, and diseases.

 

Aging and neurodegenerative diseases

Molecular mechanisms that regulate protein synthesis and degradation are central to aging and neurodegenerative diseases because they determine the integrity, quality, and adaptability of the proteome over time. High fidelity protein synthesis is required for maintaining functional proteins and prevents the buildup of aberrant translation products, while efficient degradation pathways, such as the ubiquitin–proteasome system and the autophagy–lysosome axis, remove damaged, misfolded, or aggregated proteins. With aging, both synthesis fidelity and degradative capacity decline, leading to accumulation of toxic protein species, impaired cellular stress responses, and progressive loss of neuronal resilience. In neurodegenerative disorders like Alzheimer’s, Parkinson’s, and ALS, defects in these same pathways directly drive pathogenic protein aggregation, synaptic dysfunction, and neuronal death. Thus, maintaining balanced, high-fidelity protein turnover is essential for delaying aging phenotypes and preventing neurodegeneration.

 

Slavov Laboratory

We aim to understand the rules governing emergent systems-level behavior and to use these rules to rationally engineer biological systems. We make quantitative measurements, often at the single-cell level, to test different conceptual frameworks and discriminate among different classes of models.

Slavov Laboratory

Selected Publications

Key Research Articles

Recent Research Articles

Faculty

Dec 04, 2025

New Discovery in Human Cells

BioE Professor Nikolai Slavov and his team at the Single-Cell Proteomics Center made a discovery in early human cell differences. The findings of this discovery could have a huge impact on regenerative medicine. 

Nikolai Slavov

In the Media

Oct 24, 2025

When Variant Proteins Aren’t Actually the Variant Ones

The bioRxiv preprint of BioE Professor Nikolai Slavov’s research group on “Alternate RNA decoding results in stable and abundant proteins in mammals” was featured in the Science article “When Variant Proteins Aren’t Actually the Variant Ones.”

Faculty

Sep 23, 2025

2025 Stanford University Annual Assessment of Author Citations

The following COE professors are among the top scientists worldwide selected by Stanford University representing the top 2% of the most-cited scientists with single-year impact in various disciplines. The selection is based on the top 100,000 by c-score (with and without self-citations) or a percentile rank of 2% or above.

Nikolai Slavov

Faculty

Aug 08, 2025

Decoding the Proteins Inside Every Cell

BioE Professor Nikolai Slavov, in collaboration with EMBL-EBI, Cambridge, UK, was awarded a £2,000,000 NSF grant for “Making Single-Cell Proteomics data FAIR.”

Nikolai Slavov

In the Media

May 27, 2025

Addressing Protein Leakage in Cells To Improve the Accuracy of Single-Cell Proteomic Data

Research conducted by BioE Professor Nikolai Slavov’s group was featured in the AZO Life Sciences article titled “Addressing Protein Leakage in Cells To Improve the Accuracy of Single-Cell Proteomic Data.”

Faculty

Jan 31, 2025

2024 Stanford University Annual Assessment of Author Citations

The following COE professors are among the top scientists worldwide selected by Stanford University representing the top 2% of the most-cited scientists with single-year impact in various disciplines. The selection is based on the top 100,000 by c-score (with and without self-citations) or a percentile rank of 2% or above. The list below includes those who published a paper in 2024 or later.

Faculty

Feb 26, 2024

Northeastern Among Top 100 Universities for Utility Patents

Northeastern University, recognized for its excellence in innovation and entrepreneurship, has once again been named one of the top 100 universities worldwide for securing utility patents by the National Academy of Inventors.

Faculty

Jan 22, 2024

Addressing Risk Factors and Potential Treatments of Alzheimer’s and Dementia

BioE Associate Professor Nikolai Slavov and Bouve Associate Professor Becky Briesacher provide insight into the differences between Alzheimer’s and dementia.

Faculty

Dec 07, 2023

2023 Stanford University Annual Assessment of Author Citations

The following COE professors are among the top scientists worldwide selected by Stanford University representing the top 2% of the most-cited scientists with single-year impact in various disciplines. The selection is based on the top 100,000 by c-score (with and without self-citations) or a percentile rank of 2% or above.

Faculty

Dec 04, 2023

Slowing the Progression of Alzheimer’s Disease

BioE Associate Professor Nikolai Slavov is investigating methods to slow the progression of Alzheimer’s, which is a specific form of dementia.

View All Related News